The bar graphs display the proportion of drug company’s total sales in Europe, Asia and America between 2002 and 2006.
Overall, it is clear that percentage of sales from Asia increased steadily throughout the period, while America illustrates decreasing. Europe present oscillated, but remained stil. Asia surpassed both other regions, by contrast America downtrended at least.
To begin with, Asia generated 25% of total sales, making it the lowest proportion among the regions. By following years it increased for 15% in it’s share, reaching 40% by 2006. Asia experienced a gradually uptrend throughout the period.
On the other hand, America demonstrated decline. In 2002, it taking the largest proportion of sales at 41%, but its share felt moderately over the following years, 27% in 2004 and 30% in 2006. Although starting from a top position America ended with the lowest figure among three markets.
Europe launched with 34% of total sales and indicated gradually hike, making 38% in 2004. However,t his growth shows fall thereafter 30% by 2006.
